APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical & Biotechnology IP Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical & Biotechnology IP Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchPharmaceutical & Biotechnology IP Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical & Biotechnology IP Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical & Biotechnology IP Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical & Biotechnology IP Services Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical & Biotechnology IP Services Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pharmaceutical & Biotechnology IP Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmaceutical & Biotechnology IP Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical & Biotechnology IP Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical & Biotechnology IP Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical & Biotechnology IP Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical & Biotechnology IP Services include Finnegan, MBHB, Wolf Greenfield & Sacks, P.C., Kirkland & Ellis LLP, Sterne Kessler, Nelson Mullins Riley & Scarborough LLP, Pabst Patent Group, Excelon IP and Pharma Patents International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmaceutical & Biotechnology IP Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical & Biotechnology IP Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical & Biotechnology IP Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical & Biotechnology IP Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical & Biotechnology IP Services Segment by Company

Finnegan

MBHB

Wolf Greenfield & Sacks, P.C.

Kirkland & Ellis LLP

Sterne Kessler

Nelson Mullins Riley & Scarborough LLP

Pabst Patent Group

Excelon IP

Pharma Patents International

J A Kemp

DLA Piper

Michael Best & Friedrich LLP

Troutman Pepper

Cooley LLP

Fish & Richardson

Pharmaceutical & Biotechnology IP Services Segment by Type

Patents

Copyrights

Trademarks

Others

Pharmaceutical & Biotechnology IP Services Segment by Application

Pharmaceutical Companies

Contract Research Organizations (CROs)

Others

Pharmaceutical & Biotechnology IP Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical & Biotechnology IP Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical & Biotechnology IP Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical & Biotechnology IP Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical & Biotechnology IP Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical & Biotechnology IP Services industry.

Chapter 3: Detailed analysis of Pharmaceutical & Biotechnology IP Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical & Biotechnology IP Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Patents Table 3. Key Players of Copyrights Table 4. Key Players of Trademarks Table 3. Key Players of Others Table 4. Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Companies Table 6. Key Players of Contract Research Organizations (CROs) Table 7. Key Players of Others Table 8. Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pharmaceutical & Biotechnology IP Services Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical & Biotechnology IP Services Market Share by Region (2021-2026) Table 11. Global Pharmaceutical & Biotechnology IP Services Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical & Biotechnology IP Services Market Share by Region (2027-2032) Table 13. Pharmaceutical & Biotechnology IP Services Industry Trends Table 14. Pharmaceutical & Biotechnology IP Services Industry Drivers Table 15. Pharmaceutical & Biotechnology IP Services Industry Opportunities and Challenges Table 16. Pharmaceutical & Biotechnology IP Services Industry Restraints Table 17. Global Pharmaceutical & Biotechnology IP Services Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Company (2021-2026) Table 19. Global Pharmaceutical & Biotechnology IP Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmaceutical & Biotechnology IP Services Key Company Head Office and Area Served Table 21. Global Pharmaceutical & Biotechnology IP Services Company, Product Type & Application Table 22. Global Pharmaceutical & Biotechnology IP Services Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmaceutical & Biotechnology IP Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pharmaceutical & Biotechnology IP Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Type (2021-2026) Table 29. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Type (2027-2032) Table 30. Global Pharmaceutical & Biotechnology IP Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Application (2021-2026) Table 34. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Application (2027-2032) Table 35. Finnegan Company Information Table 36. Finnegan Business Overview Table 37. Finnegan Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Finnegan Pharmaceutical & Biotechnology IP Services Product Portfolio Table 39. Finnegan Recent Development Table 40. MBHB Company Information Table 41. MBHB Business Overview Table 42. MBHB Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. MBHB Pharmaceutical & Biotechnology IP Services Product Portfolio Table 44. MBHB Recent Development Table 45. Wolf Greenfield & Sacks, P.C. Company Information Table 46. Wolf Greenfield & Sacks, P.C. Business Overview Table 47. Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Product Portfolio Table 49. Wolf Greenfield & Sacks, P.C. Recent Development Table 50. Kirkland & Ellis LLP Company Information Table 51. Kirkland & Ellis LLP Business Overview Table 52. Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 54. Kirkland & Ellis LLP Recent Development Table 55. Sterne Kessler Company Information Table 56. Sterne Kessler Business Overview Table 57. Sterne Kessler Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Sterne Kessler Pharmaceutical & Biotechnology IP Services Product Portfolio Table 59. Sterne Kessler Recent Development Table 60. Nelson Mullins Riley & Scarborough LLP Company Information Table 61. Nelson Mullins Riley & Scarborough LLP Business Overview Table 62. Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 64. Nelson Mullins Riley & Scarborough LLP Recent Development Table 65. Pabst Patent Group Company Information Table 66. Pabst Patent Group Business Overview Table 67. Pabst Patent Group Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pabst Patent Group Pharmaceutical & Biotechnology IP Services Product Portfolio Table 69. Pabst Patent Group Recent Development Table 70. Excelon IP Company Information Table 71. Excelon IP Business Overview Table 72. Excelon IP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Excelon IP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 74. Excelon IP Recent Development Table 75. Pharma Patents International Company Information Table 76. Pharma Patents International Business Overview Table 77. Pharma Patents International Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Pharma Patents International Pharmaceutical & Biotechnology IP Services Product Portfolio Table 79. Pharma Patents International Recent Development Table 80. J A Kemp Company Information Table 81. J A Kemp Business Overview Table 82. J A Kemp Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. J A Kemp Pharmaceutical & Biotechnology IP Services Product Portfolio Table 84. J A Kemp Recent Development Table 85. DLA Piper Company Information Table 86. DLA Piper Business Overview Table 87. DLA Piper Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. DLA Piper Pharmaceutical & Biotechnology IP Services Product Portfolio Table 89. DLA Piper Recent Development Table 90. Michael Best & Friedrich LLP Company Information Table 91. Michael Best & Friedrich LLP Business Overview Table 92. Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 94. Michael Best & Friedrich LLP Recent Development Table 95. Troutman Pepper Company Information Table 96. Troutman Pepper Business Overview Table 97. Troutman Pepper Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Troutman Pepper Pharmaceutical & Biotechnology IP Services Product Portfolio Table 99. Troutman Pepper Recent Development Table 100. Cooley LLP Company Information Table 101. Cooley LLP Business Overview Table 102. Cooley LLP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Cooley LLP Pharmaceutical & Biotechnology IP Services Product Portfolio Table 104. Cooley LLP Recent Development Table 105. Fish & Richardson Company Information Table 106. Fish & Richardson Business Overview Table 107. Fish & Richardson Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Fish & Richardson Pharmaceutical & Biotechnology IP Services Product Portfolio Table 109. Fish & Richardson Recent Development Table 110. North America Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026) & (US$ Million) Table 111. North America Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032) & (US$ Million) Table 112. North America Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026) & (US$ Million) Table 113. North America Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032) & (US$ Million) Table 114. North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026) Table 116. North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2027-2032) Table 117. Europe Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026) & (US$ Million) Table 118. Europe Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032) & (US$ Million) Table 119. Europe Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026) & (US$ Million) Table 120. Europe Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032) & (US$ Million) Table 121. Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026) Table 123. Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2027-2032) Table 124. China Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026) & (US$ Million) Table 125. China Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032) & (US$ Million) Table 126. China Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026) & (US$ Million) Table 127. China Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032) & (US$ Million) Table 128. Asia Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026) & (US$ Million) Table 129. Asia Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032) & (US$ Million) Table 130. Asia Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026) & (US$ Million) Table 131. Asia Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia Pharmaceutical & Biotechnology IP Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026) Table 134. Asia Pharmaceutical & Biotechnology IP Services Market Size by Country (2027-2032) Table 135. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026) & (US$ Million) Table 136. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032) & (US$ Million) Table 137. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026) & (US$ Million) Table 138. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032) & (US$ Million) Table 139. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026) Table 141. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Pharmaceutical & Biotechnology IP Services Product Image Figure 2. Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmaceutical & Biotechnology IP Services Market Share by Type: 2025 VS 2032 Figure 4. Patents Image Figure 5. Copyrights Image Figure 6. Trademarks Image Figure 7. Others Image Figure 8. Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pharmaceutical & Biotechnology IP Services Market Share by Application: 2025 VS 2032 Figure 10. Pharmaceutical Companies Image Figure 11. Contract Research Organizations (CROs) Image Figure 12. Others Image Figure 13. Global Pharmaceutical & Biotechnology IP Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 15. Global Pharmaceutical & Biotechnology IP Services Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Pharmaceutical & Biotechnology IP Services Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Pharmaceutical & Biotechnology IP Services Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pharmaceutical & Biotechnology IP Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Type (2021-2032) Figure 22. Global Pharmaceutical & Biotechnology IP Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Application (2021-2032) Figure 24. North America Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032) Figure 26. North America Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032) Figure 27. North America Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032) Figure 28. United States Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 29. Canada Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032) Figure 33. Europe Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032) Figure 34. Europe Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032) Figure 35. Germany Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 36. France Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 38. Italy Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 39. Russia Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 41. China Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 42. China Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032) Figure 43. China Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032) Figure 44. Asia Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 45. Asia Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032) Figure 46. Asia Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032) Figure 47. Asia Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032) Figure 48. Japan Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 52. India Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 53. Australia Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032) Figure 58. Brazil Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 63. UAE Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 65. Chile Pharmaceutical & Biotechnology IP Services Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Patents
  • Copyrights
  • Trademarks
  • Others
Applications
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others
Companies covered
  • Finnegan
  • MBHB
  • Wolf Greenfield & Sacks, P.C.
  • Kirkland & Ellis LLP
  • Sterne Kessler
  • Nelson Mullins Riley & Scarborough LLP
  • Pabst Patent Group
  • Excelon IP
  • Pharma Patents International
  • J A Kemp
  • DLA Piper
  • Michael Best & Friedrich LLP
  • Troutman Pepper
  • Cooley LLP
  • Fish & Richardson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Patents
  5. 1.2.3 Copyrights
  6. 1.2.4 Trademarks
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Companies
  11. 1.3.3 Contract Research Organizations (CROs)
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Pharmaceutical & Biotechnology IP Services Growth Trends by Region
  15. 1.5.1 Global Pharmaceutical & Biotechnology IP Services Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Pharmaceutical & Biotechnology IP Services Market Size by Region (2021-2026)
  17. 1.5.3 Pharmaceutical & Biotechnology IP Services Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Pharmaceutical & Biotechnology IP Services Market Dynamics
  1. 2.1 Pharmaceutical & Biotechnology IP Services Industry Trends
  2. 2.2 Pharmaceutical & Biotechnology IP Services Industry Drivers
  3. 2.3 Pharmaceutical & Biotechnology IP Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical & Biotechnology IP Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmaceutical & Biotechnology IP Services Revenue by Company (2021-2026)
  2. 3.2 Global Pharmaceutical & Biotechnology IP Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmaceutical & Biotechnology IP Services Key Company Head office and Area Served
  4. 3.4 Global Pharmaceutical & Biotechnology IP Services Company, Product Type & Application
  5. 3.5 Global Pharmaceutical & Biotechnology IP Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmaceutical & Biotechnology IP Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmaceutical & Biotechnology IP Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmaceutical & Biotechnology IP Services Tier 1, Tier 2, and Tier 3
4 Pharmaceutical & Biotechnology IP Services Market by Type
  1. 4.1 Global Pharmaceutical & Biotechnology IP Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2032)
  3. 4.3 Global Pharmaceutical & Biotechnology IP Services Market Size Share by Type (2021-2032)
5 Pharmaceutical & Biotechnology IP Services Market by Application
  1. 5.1 Global Pharmaceutical & Biotechnology IP Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2032)
  3. 5.3 Global Pharmaceutical & Biotechnology IP Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Finnegan
  2. 6.1.1 Finnegan Company Information
  3. 6.1.2 Finnegan Business Overview
  4. 6.1.3 Finnegan Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Finnegan Pharmaceutical & Biotechnology IP Services Product Portfolio
  6. 6.1.5 Finnegan Recent Developments
  7. 6.2 MBHB
  8. 6.2.1 MBHB Company Information
  9. 6.2.2 MBHB Business Overview
  10. 6.2.3 MBHB Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 MBHB Pharmaceutical & Biotechnology IP Services Product Portfolio
  12. 6.2.5 MBHB Recent Developments
  13. 6.3 Wolf Greenfield & Sacks, P.C.
  14. 6.3.1 Wolf Greenfield & Sacks, P.C. Company Information
  15. 6.3.2 Wolf Greenfield & Sacks, P.C. Business Overview
  16. 6.3.3 Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Product Portfolio
  18. 6.3.5 Wolf Greenfield & Sacks, P.C. Recent Developments
  19. 6.4 Kirkland & Ellis LLP
  20. 6.4.1 Kirkland & Ellis LLP Company Information
  21. 6.4.2 Kirkland & Ellis LLP Business Overview
  22. 6.4.3 Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Product Portfolio
  24. 6.4.5 Kirkland & Ellis LLP Recent Developments
  25. 6.5 Sterne Kessler
  26. 6.5.1 Sterne Kessler Company Information
  27. 6.5.2 Sterne Kessler Business Overview
  28. 6.5.3 Sterne Kessler Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sterne Kessler Pharmaceutical & Biotechnology IP Services Product Portfolio
  30. 6.5.5 Sterne Kessler Recent Developments
  31. 6.6 Nelson Mullins Riley & Scarborough LLP
  32. 6.6.1 Nelson Mullins Riley & Scarborough LLP Company Information
  33. 6.6.2 Nelson Mullins Riley & Scarborough LLP Business Overview
  34. 6.6.3 Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Product Portfolio
  36. 6.6.5 Nelson Mullins Riley & Scarborough LLP Recent Developments
  37. 6.7 Pabst Patent Group
  38. 6.7.1 Pabst Patent Group Company Information
  39. 6.7.2 Pabst Patent Group Business Overview
  40. 6.7.3 Pabst Patent Group Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pabst Patent Group Pharmaceutical & Biotechnology IP Services Product Portfolio
  42. 6.7.5 Pabst Patent Group Recent Developments
  43. 6.8 Excelon IP
  44. 6.8.1 Excelon IP Company Information
  45. 6.8.2 Excelon IP Business Overview
  46. 6.8.3 Excelon IP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Excelon IP Pharmaceutical & Biotechnology IP Services Product Portfolio
  48. 6.8.5 Excelon IP Recent Developments
  49. 6.9 Pharma Patents International
  50. 6.9.1 Pharma Patents International Company Information
  51. 6.9.2 Pharma Patents International Business Overview
  52. 6.9.3 Pharma Patents International Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pharma Patents International Pharmaceutical & Biotechnology IP Services Product Portfolio
  54. 6.9.5 Pharma Patents International Recent Developments
  55. 6.10 J A Kemp
  56. 6.10.1 J A Kemp Company Information
  57. 6.10.2 J A Kemp Business Overview
  58. 6.10.3 J A Kemp Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 J A Kemp Pharmaceutical & Biotechnology IP Services Product Portfolio
  60. 6.10.5 J A Kemp Recent Developments
  61. 6.11 DLA Piper
  62. 6.11.1 DLA Piper Company Information
  63. 6.11.2 DLA Piper Business Overview
  64. 6.11.3 DLA Piper Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 DLA Piper Pharmaceutical & Biotechnology IP Services Product Portfolio
  66. 6.11.5 DLA Piper Recent Developments
  67. 6.12 Michael Best & Friedrich LLP
  68. 6.12.1 Michael Best & Friedrich LLP Company Information
  69. 6.12.2 Michael Best & Friedrich LLP Business Overview
  70. 6.12.3 Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Product Portfolio
  72. 6.12.5 Michael Best & Friedrich LLP Recent Developments
  73. 6.13 Troutman Pepper
  74. 6.13.1 Troutman Pepper Company Information
  75. 6.13.2 Troutman Pepper Business Overview
  76. 6.13.3 Troutman Pepper Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Troutman Pepper Pharmaceutical & Biotechnology IP Services Product Portfolio
  78. 6.13.5 Troutman Pepper Recent Developments
  79. 6.14 Cooley LLP
  80. 6.14.1 Cooley LLP Company Information
  81. 6.14.2 Cooley LLP Business Overview
  82. 6.14.3 Cooley LLP Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Cooley LLP Pharmaceutical & Biotechnology IP Services Product Portfolio
  84. 6.14.5 Cooley LLP Recent Developments
  85. 6.15 Fish & Richardson
  86. 6.15.1 Fish & Richardson Company Information
  87. 6.15.2 Fish & Richardson Business Overview
  88. 6.15.3 Fish & Richardson Pharmaceutical & Biotechnology IP Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Fish & Richardson Pharmaceutical & Biotechnology IP Services Product Portfolio
  90. 6.15.5 Fish & Richardson Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical & Biotechnology IP Services Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical & Biotechnology IP Services Market Size by Type
  3. 7.2.1 North America Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032)
  6. 7.3 North America Pharmaceutical & Biotechnology IP Services Market Size by Application
  7. 7.3.1 North America Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032)
  10. 7.4 North America Pharmaceutical & Biotechnology IP Services Market Size by Country
  11. 7.4.1 North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical & Biotechnology IP Services Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical & Biotechnology IP Services Market Size by Type
  3. 8.2.1 Europe Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmaceutical & Biotechnology IP Services Market Size by Application
  7. 8.3.1 Europe Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmaceutical & Biotechnology IP Services Market Size by Country
  11. 8.4.1 Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmaceutical & Biotechnology IP Services Market Size (2021-2032)
  2. 9.2 China Pharmaceutical & Biotechnology IP Services Market Size by Type
  3. 9.2.1 China Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032)
  6. 9.3 China Pharmaceutical & Biotechnology IP Services Market Size by Application
  7. 9.3.1 China Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmaceutical & Biotechnology IP Services Market Size (2021-2032)
  2. 10.2 Asia Pharmaceutical & Biotechnology IP Services Market Size by Type
  3. 10.2.1 Asia Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmaceutical & Biotechnology IP Services Market Size by Application
  7. 10.3.1 Asia Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmaceutical & Biotechnology IP Services Market Size by Country
  11. 10.4.1 Asia Pharmaceutical & Biotechnology IP Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmaceutical & Biotechnology IP Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst